A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

Fiedler, Walter; Kayser, Sabine; Kebenko, Maxim; Janning, Melanie; Krauter, Juergen; Schittenhelm, Marcus; Goetze, Katharina; Weber, Daniela; Goehring, Gudrun; Teleanu, Veronica; Thol, Felicitas; Heuser, Michael; Doehner, Konstanze; Ganser, Arnold; Doehner, Hartmut; Schlenk, Richard F.

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

A phase I/II study of sunitinib and intensive chemotherapy in patients over 60 years of age with acute myeloid leukaemia and activating FLT3 mutations

Author:

Fiedler, Walter; Kayser, Sabine; Kebenko, Maxim; Janning, Melanie; Krauter, Juergen; Schittenhelm, Marcus; Goetze, Katharina; Weber, Daniela; Goehring, Gudrun; Teleanu, Veronica; Thol, Felicitas; Heuser, Michael; Doehner, Konstanze; Ganser, Arnold; Doehner, Hartmut; Schlenk, Richard F.

Tübinger Autor(en):

Schittenhelm, Marcus Matthias

Published in:

British Journal of Haematology (2015), Bd. 169, H. 5, S. 694-700

Verlagsangabe:

Wiley - Blackwell

Language:

English

Full text:

http://dx.doi.org/10.1111/bjh.13353

ISSN:

0007-1048